Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK Oct 17, 2019 | Glioblastoma
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer. Oct 8, 2019 | Colorectal Cancer
Innate and adaptive immunotherapy: An orchestration of immunogenic cell death by overcoming immune suppression and activating NK and T-cell therapy in patients with third line or greater Triple-Negative Breast Cancer (TNBC) May 26, 2019 | Triple Negative Breast Cancer
Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs. Feb 12, 2019 | Lassa Fever
